NA

Nabla Bio

YC S20 ↗

Boston, US · Founded 2020 · 8 employees · 8 known investors

nabla.bio ↗

Nabla is a drug development company that applies design discipline and scientific rigor to the development of new medicines. The company focuses on making drug development more systematic and iterative, serving the pharmaceutical and biotech industry.

Founders & leadership· Y Combinator alumni (S20)

SB

Surge Biswasin𝕏Founder

FA

Frances AnastassacosinFounder

Investors · 8

FI

Fifty YearsSan Francisco · $250K – $2M

PI

Pillar VCBoston · $50K – $4M

RA

Radical VenturesToronto · $1M – $25M

Y

Y CombinatorSan Francisco · $500K

ZE

Zetta Venture PartnersSan Francisco · $1M – $5M

BO

Boom Capital VenturesreportedSan Francisco · $50K – $300Kvia Celestine Schnugg · inferred

CA

Cantos VenturesreportedSan Francisco · $400K – $1.5M

KH

Khosla VenturesreportedMenlo Park · $5K – $50M